About Sufra
Expert-led from day one.
Sufra is an expert-led investment firm backing seed-stage healthtech companies with capital, clinical deployment infrastructure, and institutional access. We were built by people who've worked inside health systems, and we invest like it.
Our Mission
What we do
We invest $100–500K at seed stage and immediately activate a Strike Team, a well-rounded team of experts who pilot the product, generate early traction, and translate that traction into institutional access.
Why it matters
Most healthtech companies don't fail because the product doesn't work. They fail because it never gets deployed. Sufra was built to solve the deployment problem, not just the capital problem.
Founder
Ahmad Saleh
Founder & Managing Partner
Ahmad Saleh spent a decade on the commercial and product side of digital health — at AliveCor, iRhythm, and Vivalink — helping bring millions of devices to market, navigating multiple FDA submissions, and contributing to 22 patents across connected health hardware and software. He has been inside the rooms where healthtech products are built, cleared, and sold at scale.
He watched the same pattern repeat throughout. The technology worked. The pilots stalled. The problem was never invention. It was adoption.
Sufra Health Ventures is his answer. An investment platform built on the belief that capital alone does not move healthcare. Ahmad assembles a Strike Team of clinical operators, practice owners, and domain experts into every portfolio company after close — the people who know how health systems actually buy, pilot, and scale new tools. Not as advisors. As investors with skin in the game.
Who we serve
Founders
Pre-seed and seed-stage healthtech startups seeking capital, clinical validation, and commercial partnerships.
Expert Network
Clinicians, MedTech experts, and industry leaders who want to advise, invest in, or pilot early-stage solutions.
Investors
Angels and syndicate members who want curated deal flow with built-in expert diligence from the network.
The Sufra Perspective
Healthcare investing is capital-rich and execution-poor.
There is no shortage of money flowing into healthtech. The shortage is in the people who understand how to deploy technology inside clinical settings, and who are willing to stake their reputation on it.
Sufra fills that gap. We are investors who have operated inside health systems, and operators who are willing to invest. That alignment is rare. We think it's the only way to build companies that actually reach patients.
Built-in Principles
01
Skin in the game
Operators who invest capital and time produce different outcomes than those who advise from a distance. We require both.
02
Execution, not access
A warm introduction is not a deliverable. A live pilot inside a real practice within 90 days is.
03
Every seat filled
Every stage of company growth needs domain expertise at the table. Diligence. Distribution. Reimbursement. Go-to-market. We staff all of it.
04
Aligned outcomes
Our operators earn carry. Founders get real deployment. Investors get differentiated deal flow. Nobody wins unless the company wins.
Frequently Asked Questions
We invest at seed stage, typically before product-market fit is obvious, and often before a company has enterprise customers. We move early because our Strike Team model is most valuable when there's still time to shape product-market fit.
We assemble a well-rounded team of experts for each portfolio company at close. The team is built to create value for that specific company and may include clinicians, practice owners, distribution partners, and commercial operators. They pilot the product, refer patients, give structured product feedback, and open access to a network of pilots inside real clinical settings.
Most seed funds provide capital and introductions. Sufra provides capital and a clinical deployment infrastructure: experts who pilot, refer, and close. That's not advisory; it's active customer generation built into the investment model.
Practicing clinicians, practice owners, and health system leaders who want to engage with early-stage healthtech companies by piloting products, advising on clinical workflows, and earning advisor equity in the companies they believe in. Membership is selective.
Get Involved
No healthtech company should navigate this alone. Healthcare is the hardest distribution problem in any industry. The companies that break through do it with operators who have already been inside the system and know every seat at the table.